Fluoxetine causes decrease in intestinal motility

Ayesha Afzal, Madam Bushra Tayabba Khan, Mahjabeen Sharif

Abstract


Background: Major depression is the most frequent disorder occurring in 16% of the population worldwide. In the middle of the 20th century, the discovery of selective serotonin (5-HT) reuptake inhibitors acted as a miracle in the antidepressant therapy. We explored the acute effects of fluoxetine and possible mechanism underlying the contractile effects of fluoxetine on isolated ileal smooth muscles of rabbit in vitro.

Methods: Effects of increasing concentrations of acetylcholine (Ach), 5-HT and fluoxetine were studied on isolated ileal tissue of the rabbit in vitro by constructing cumulative concentration response curves. The ileal smooth muscle contractions were recorded on power lab (USA).

Results: Ach, 5-HT and fluoxetine, produced a concentration-dependent reversible contraction of isolated ileal muscle of rabbit. The mean ± standard error of the mean of maximum amplitudes of contraction with Ach, 5-HT and fluoxetine, were 24.8±1.22 mm, 44±0.527 mm and 2.6±1.16 mm, respectively. Fluoxetine shifted the concentration-response curve right and downwards.

Conclusion: Our study has indicated that fluoxetine on isolated ileal intestinal smooth muscle decrease the motility and this decrease in motility is possibly due to the inability of fluoxetine in vitro to enhance the serotonergic transmission and also because of the interaction of these agents with some of the other receptors, present in the intestinal smooth muscles.


Keywords


Serotonin, Fluoxetine, Acetylcholine, Gastrointestinal tract, Diarrhea

Full Text:

PDF

References


Ferrés-Coy A, Pilar-Cuellar F, Vidal R, Paz V, Masana M, Cortés R, et al. RNAi-mediated serotonin transporter suppression rapidly increases serotonergic neurotransmission and hippocampal neurogenesis. Transl Psychiatry. 2013;3:e211.

Camilleri M. Serotonergic modulation of visceral sensation: lower gut. Gut. 2002;51 Suppl 1:i81-6.

Coates MD, Johnson AC, Greenwood-Van Meerveld B, Mawe GM. Effects of serotonin transporter inhibition on gastrointestinal motility and colonic sensitivity in the mouse. Neurogastroenterol Motil. 2006;18(6):464-71.

Rand JB. Acetylcholine. WormBook. 2007;1-21.

Noor A, Najmi MH, Bukhtiar S. Effect of Montelukast on bradykinin-induced contraction of isolated tracheal smooth muscle of guinea pig. Indian J Pharmacol. 2011;43(4):445-9.

Jabeen Q, Aziz N, Afzal Z, Gilani HA. The spasmogenic and spasmolytic activities of lavandula stoechas are mediated through muscarinic receptor stimulation and calcium channel blockade. Int J Pharmacol. 2007;3(1):61-7.

Tuladhar BR, Costall B, Naylor RJ. Modulation of 5-HT4 receptor function in the rat isolated ileum by fluoxetine: the involvement of endogenous 5-hydroxytryptamine. Br J Pharmacol. 2002;136(1):150-6.

Tanko Y, Alladey O, Ahmad KM, Muhammad A, Musa KY. The effect of methanol leaves extract of Ficus Glumosa on gastrointestinal motility and castor oil induced diarrhoe in laboratory animals. Scholar Res Libr. 2012;2(3):360-7.

Chetty N, Irving HR, Coupar IM. Activation of 5-HT3 receptors in the rat and mouse intestinal tract: a comparative study. Br J Pharmacol. 2006;148(7):1012-21.

Spiller R. Serotonergic modulating drugs for functional gastrointestinal diseases. Br J Clin Pharmacol. 2002;54(1):11 20.

Pithadia AB, Jain SM. 5-Hydroxytryptamine receptor subtypes and their modulators with therapeutic potentials. J Clin Med Res. 2009;1(2):72-80.

Mujezinovic I, Cupic V, Samajlovic A, Muminovic M. Identification of serotonergic (5-H1A-Type) receptor in broiler small intestine by application of its serotonin and antagonist. Vet Glasnick. 2011;65(2):51-9.

Carr GV, Lucki I. The role of serotonin receptor subtypes in treating depression: a review of animal studies. Psychopharmacology (Berl). 2011;213(2-3):265-87.